Brian Varnum - 13 Apr 2022 Form 4 Insider Report for Armata Pharmaceuticals, Inc. (ARMP)

Role
President and CEO
Signature
/s/ Todd R. Patrick, attorney-in-fact
Issuer symbol
ARMP
Transactions as of
13 Apr 2022
Transactions value $
$0
Form type
4
Filing time
15 Apr 2022, 15:46:48 UTC
Previous filing
03 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARMP Stock Options (Right to Buy) Award $0 +240K $0.00 240K 13 Apr 2022 Common Stock 240K $5.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to twenty-five percent (25%) of the underlying shares of common stock on each of the first, second, third and fourth annual anniversaries of the date of grant.